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Introduction. Autoinflammatory diseases are a group of genetically inherited disorders 
and familial Mediterranean fever is the most common of this group. It is rare in other 
than Middle East populations. Clinical manifestations of FMF are attacks of fever usual-
ly shorter than 24 hours, associated with arthritis, pleuritic chest pain, and abdominal 
pain.  
Case presentation. A 15-year-old female patient was included in the study. She com-
plained of recurrent episodes of fever associated with arthritis and abdominal pain. 
Moreover, the patient presented dysmorphic features like hyperthelorism, prognathia, 
scoliosis, pectus carinatum, and hypermobility syndrome. The laboratory exam revealed 
mutations in both MEVF and SMAD 3.  
Conclusions. An autoinflammatory disorder should be suspected in any patient who 
has a history of recurrent fever.  The attack patterns of FMF varies not just in different 
patients, but also in the same patient. Mainstay of treatment is colchicine that signifi-
cantly improves the prognosis of patients with FMF. 
Cuvinte cheie: boli 
autoinflamatorii, febră 
mediteraneană  familială, 
copii. 
DIFICULTĂȚI DIAGNOSTICE: COEXISTENȚA A DOUĂ BOLI RARE – FEBRA MEDI-
TERANEANA FAMILIALĂ ȘI SINDROMUL LOEYS-DIETZ  TIP 3  
Introducere. Bolile autoinflamatorii constituie un grup de maladii determinate de 
activarea aberantă a căilor inflamatorii. FMF este cea mai frecventă 
afecțiune autoinflamatorie. Cu excepția țărilor din Orientul Mijlociu, FMF se întâlnește 
rar. Manifestările clinice includ episoade febrile cu o durată ce nu depășește  24 ore, 
fiind asociate cu artrită, durere abdominală și de tip pleuritic.  
Prezentarea cazului. Pacientă de 15 ani,  inclusă în studiu.  S-a adresat cu acuze 
de  episoade febrile recurente, asociate cu artrită și dureri abdominale. La examenul 
clinic pacienta prezenta dismorfisme: hipertelorism, prognație, pectus carinatum, sin-
drom de hipermobilitate. La examenul de laborator au fost depistate mutații în genele 
MEVF și SMAD 3. 
Concluzii. Un sindrom autoinflamator va fi suspectat la pacienții cu istoric de febră 
recurentă. Patternul atacurilor în FMF este variabil nu doar la diferiți pacienți, ci și în 
cazul aceluiași bolnav. Baza terapiei este colchicina, care a ameliorat substanțial pro-
gnosticul pacienților cu FMF. 
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INTRODUCTION 
Autoinflammatory diseases are a group of gene-
tically inherited disorders, caused by inadequate 
activation of inflammatory pathways it the ab-
sence of antigen directed autoimmunity. Periodic 
fever is the most common manifestation (1, 2). 
An autoinflammatory disorder should be sus-
pected in any patient who presents a history of 
recurrent fever over years and months. Most 
patients present first symptoms in early child-
hood. The clinical picture include fever, rashes, 
serositis, arthritis, meningitis, and uveitis. Clini-
cal patterns should be evaluated to check if it 
refers to an autoinflammatory condition [2]. Next, 
genetic tests should be carried out in order to 
confirm the presumptive diagnosis (3). 
Familial Mediterranean fever is the most com-
mon autoinflammatory disease. Its prevalence is 
1:250-1:1000 in Middle East population, but rare 
in other populations. The cause is the mutation 
in MEVF gene located on chromosome 16 (4). 
The attack lasts 12-72, showing the following 
characteristics: fever, aseptic peritonitis, pleurit-
ic thoracic pain, erysipel-like rash, headache 
(rare), orchitis (rare), and arthralgia/arthritis 
(children – oligoarthritis). During the febrile 
episode, a high number of neutrophils and acute 
phase reactants can be noted. The diagnosis is 
confirmed by genetic testing, although it remains 
a clinical one. It is based on a history of recur-
rent, self-limited attacks of fever and serositis 
that are prevented by colchicine (2, 4, 5). 
 
CASE PREZENTATION 
A 15-year-old female was admitted to the Rheu-
matology unit, complaining of a recurrent fever 
(2-6 times per month), up to 40°C, associated 
with nausea, vomiting, sometimes abdominal 
pain; fever commonly lasts no more than 24 
hours and does not respond to fever medication. 
In addition, she complained of non-inflammatory 
joint pain, myalgia after mild physical exertion, 
fatigability and migraine.   
The disease history revealed that the first febrile 
episode of unknown etiology and increased lev-
els of acute phase reactants occurred during in-
fancy. She had many episodes, interpreted as 
upper respiratory tract infections and urinary 
tract infections. Moreover, at the age of 4, the 
patient had the first episode of arthritis. At the 
age of 8 she was admitted to hospital for being 
suspected of peritonitis. At the age of 8, she was 
diagnosed with juvenile oligoarthritis, but the 
patient did not return for follow-up monitoring. 
At the age of 15, the patient presented again at 
the rheumatologist and a diagnostic plan was set 
up.  
The patient was born from uneventful pregnan-
cy, breastfed until 1 year of age and vaccinated 
according to the national schedule. Patient did 
not report any allergies.  
Family history was negative for autoimmune, 
immunodeficiency or genetic diseases. Patient’s 
mother was diagnosed with migraine. 
The patient was clinically and paraclinically ex-
amined within the Rheumatology unit. 
Patient’s clinical examination revealed that she 
was underweight (BMI 16.6, -1.61 SDS), having 
astenic constitution and deformities of the thor-
ax – pectus carinatum and thoracolumbar scolio-
sis. On the lower limbs – multiple excoriations 
and bruises (according to patient’s mother the 
girl presented a delayed wound healing). On in-
spection, hypertelorism and prognatia were also 
revealed. Patient wore braces for orthodontic 
treatment. Musculoskeletal system exam re-
vealed hypermobility syndrome (Beighton score 
of 8 points) and pes planus. Respiratory and car-
diovascular examination were normal (including 
blood pressure – percentile 50 for age and 
height).  No hepatomegaly or splenomegaly were 
revealed on abdominal exam. 
The laboratory exam recorded normal values of 
differential CBC, biochemical test (renal function, 
liver panel, metabolic panel), and urine test. C-
reactive protein was positive (6 mg/dL). Serum   
amyloid was 24 mg/L (normal value <10mg/L). 
The internal organ ultrasound imaging of kid-
neys and heart was normal. Antinuclear antibody 
screening test, as well as immunoblot for auto-
immune disease were negative. Also, the immu-
noglobulin levels were assessed, and flow-
cytometry was performed.  The study findings 
are presented in Table 1. 
Due to multiple stigma, a genetic test for cone-
ctive tissue diseases was carried out. Also, consi-
dering the recurrent fever, the autoinflammatory 
panel was added. Finally, the patient was found 
positive to mutations Chr16:3293407T>C,               
p. Met694Val and Chr16:3293405T>C, p. 
Met694Ile on gene MEVF, both having pathologic 
significance.
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Table 1. Immunoglobuline levels and flow-cytometry results. 
 
 
Prior to the treat-
ment 
After 3 months of 
treatment 
Reference Units 
SAA 24 20 <10 mg/L 
Lymphocytes 31.8 29.1 36-43 
% 
CD3+ 78.98 78 66-76 
CD4+ 54.61 54 33-41 
CD8+ 19.79 20 27-35 
CD16+ 3.71 6 9.9-22.9 
Monocytes 9.1 7.9 4-8 
Lymphocytes 1749 1775 2000-2700 
cells/uL 
CD3+ 1381.4 1384 1400-2000 
CD8+ 346.1 355 600-1900 
CD19+ 243.5 284 300-500 
CD16+ 64.8 106 100-500 
CD4/CD8 2.76 2.7  
 
Furthermore, a pathologically significant muta-
tion in gene SMAD 3 – Chr15: 67477068G>C was 
revealed.  
Therefore, based on EUROFEVER/PRINTO a di-
agnosis of familial Mediterranean fever was 
made. Furthermore, based on the presence of 
confirmatory mutation on the gene SMAD 3, a 
diagnosis of Loyez-Dietz syndrome was also es-
tablished.  
Treatment with colchicine 1 mg/24h was initiat-
ed. Over half a year, the attack intensity of mark-
edly decreased, as well as their frequency. 
 
DISCUSSIONS 
Autoinflammatory diseases are a group of gene-
tically inherited disorders, caused by inadequate 
activation of inflammatory pathways it the ab-
sence of antigen directed autoimmunity. Periodic 
fever is the most common manifestation. The 
spectrum of the autoinflammatory disorders is 
extending continuously, and now include not just 
Il-1 mediated diseases but also those that don’t 
include fever as a major sign (1, 2). 
An autoinflammatory disorder should be sus-
pected in any patient who presents with a histo-
ry of recurrent fever over years and months. 
Most patients present first symptoms in early 
childhood. The clinical picture include fever, 
rashes, serositis, arthritis, meningitis, uveitis. 
Clinical patterns should be evaluated to check if 
it is related to an autoinflammatory condition. 
Next, a genetic test should be ordered in order to 
confirm the presumptive diagnosis (1, 2, 3, 6). 
Differential  will  include  recurrent  fever,  mali- 
gnancies, systemic onset juvenile idiopathic ar-
thritis. 
Familial Mediterranean fever is the most com-
mon autoinflammatory disease. Its prevalence is 
1:250-1:1000 in the Middle East population, but 
rarely occurs in other populations. The cause is 
the mutation in MEVF gene located on chromo-
some 16. This mutation is a gain of function mu-
tation, so it stimulates uncontrolled production 
of Il-1. It has both, autosomal recessive and auto-
somal dominant transmission (1, 3, 4). 
Nowadays, there are around 300 mutations de-
scribed; all of them are registered in the INFE-
VERS database. Not all the mutations are asso-
ciated with FMF phenotype and its significance is 
not clear. The most common mutations that are 
associated with FMF are p.M694V, M694I, M680I 
and V726A. Mutations localized on 10 th exon are 
considered to be the most severe. In our pa-
tient’s case, there are two different mutations – 
p.M694V (Ancestry – Jewish Non Ashkenasi), 
M694I (Ancestry – Maghrebian), both located on 
10th exon. Therefore, is expected to have a severe 
disease, with a chance not to respond to colchi-
cine treatment (4, 6). 
Clinical features. Usually, a patient with FMF pre-
sents the first symptom by the age of 20. The 
duration of the attack is 12-72 hours, showing 
the following characteristics: fever, aseptic peri-
tonitis, pleuritic thoracic pain, erysipel-like rash, 
headache (rare), orchitis (rare), and arthral-
gia/arthritis (children – oligoarthritis). During 
the febrile episode, a high number of neutrophils 
and  acute  phase  reactants  can  be noted. The at 
tack  patterns  vary  not  just in different patients,  
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but also in the same patient. The mechanism that 
triggers the attack is unknown, but many pa-
tients complain of physical and psychological 
exhaustion, associated with the onset of the at-
tack (2,4). 
 
Eurofever/PRINTO  
Familial Mediterranean Fever criteria 
Presence of a confirmatory MEVF genotype and at least one ot the above:  
• Duration of febrile episodes 1-3 days 
• Arthritis 
• Pleuritic pain 
• Abdominal pain 
 
OR 
 
Presence of a nonconfirmatory MEVF genotype and at least two of the above: 
• Duration of febrile episodes 1-3 days 
• Arthritis 
• Pleuritic pain 
• Abdominal pain 
Sensitivity 0.94 
Specificity 0.95 
Accuracy 0.98 
 
The diagnosis is confirmed by genetic testing but 
mostly remains a clinical one. It is based on a 
history of recurrent, self-limited attacks of fever 
and serositis that are prevented by colchicine. 
Treatment. Colchicine licenced by FDA is used for 
prophylactic use in case of FMF from the age of 4. 
Continuous use of colchicine prevents or reduces 
substantially the symptoms of FMF in at least 
95% and almost completely excludes the risk of 
amiloidosis. The mechanism of action of colchi-
cine is unknown, but most of patients have a 
good clinical  response  to doses  250 mg-2g/24h 
(7, 8). 
Complications. The treatment is necessary to be  
continued throughout the whole life, and the 
prognosis is favorable, having a good life expec-
tancy. Prior to use of colchicine, 60% of patients 
with FMF develop amiloidosis. Destructive ar-
thritis is rare. Growth and fertility are nearly 
normal for both sexes (in case of treatment ad-
herence) (5, 7, 8). 
The described case is unique – there are no regi-
stered patients with FMF in the Republic of Mol-
dova. Furthermore, our patient exhibited clinical 
features not just of an autoinflammatory syn-
drome, but also of a hereditary connective tissue 
disease, that made the clinical diagnosis even 
more complicated. 
 
CONCLUSIONS 
1. Autoinflammatory diseases are a group of genetically inherited disorders,  caused by inadequate 
activation of inflammatory pathways. Familial Mediterranean fever is the most common autoin-
flammatory disease, with the highest prevalence among Middle East population that rarely occur in 
other populations.  
2. Clinical manifestations of FMF are attacks of fever usually shorter than 24 hours, associated with 
arthritis, pleuritic chest pain, and abdominal pain. Pattern of attacks varies not just in different pa-
tients, but also in the same patient. The mainstay of treatment is colchicine that significantly im-
proves the prognosis of patients with FMF. 
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